
Becton, Dickinson and Company BDX
$ 200.48
-0.23%
Annual report 2025
added 11-25-2025
Becton, Dickinson and Company Depreciation & Amortization 2011-2025 | BDX
Annual Depreciation & Amortization Becton, Dickinson and Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.46 B | 2.29 B | 2.29 B | 2.23 B | 2.23 B | 2.12 B | 2.25 B | 1.98 B | 1.09 B | 1.11 B | 891 M | 562 M | 546 M | 511 M | 494 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.46 B | 494 M | 1.54 B |
Quarterly Depreciation & Amortization Becton, Dickinson and Company
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 397 M | 396 M | 607 M | 362 M | 366 M | 561 M | 367 M | 366 M | 567 M | - | 357 M | 352 M | 546 M | - | 1.11 B | 350 M | 555 M | 1.6 B | 1.07 B | 555 M | 530 M | 1.7 B | 1.13 B | 530 M | 563 M | 1.41 B | 844 M | 563 M | 291 M | 802 M | 523 M | 291 M | 262 M | 841 M | 569 M | 262 M | 289 M | 576 M | 277 M | 289 M | 139 M | 413 M | 272 M | 139 M | 142 M | 404 M | 265 M | 142 M | 129 M | 384 M | 261 M | 129 M | 133 M | -365 M | -245 M | 136 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.7 B | -365 M | 472 M |
Depreciation & Amortization of other stocks in the Medical instruments industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioLife Solutions
BLFS
|
5.16 M | $ 24.56 | 0.7 % | $ 1.13 B | ||
|
Baxter International
BAX
|
997 M | $ 19.52 | 1.93 % | $ 9.96 B | ||
|
Ekso Bionics Holdings
EKSO
|
1.61 M | $ 4.68 | 0.21 % | $ 94.4 M | ||
|
Harvard Bioscience
HBIO
|
1.47 M | $ 0.71 | -4.45 % | $ 30.1 M | ||
|
ICU Medical
ICUI
|
220 M | $ 148.28 | -0.1 % | $ 3.62 B | ||
|
iRhythm Technologies
IRTC
|
20.7 M | $ 170.21 | 0.82 % | $ 5.31 B | ||
|
AtriCure
ATRC
|
11.2 M | $ 41.07 | -3.09 % | $ 1.93 B | ||
|
Atrion Corporation
ATRI
|
15.1 K | - | - | $ 810 M | ||
|
electroCore
ECOR
|
962 K | $ 4.85 | 2.11 % | $ 26.7 K | ||
|
Repro Med Systems
KRMD
|
870 K | $ 5.8 | 0.35 % | $ 264 M | ||
|
AngioDynamics
ANGO
|
25.8 M | $ 13.42 | 2.13 % | $ 548 M | ||
|
The Cooper Companies
COO
|
377 M | $ 81.36 | -0.88 % | $ 16.2 B | ||
|
LeMaitre Vascular
LMAT
|
9.67 M | $ 83.04 | -1.14 % | $ 1.86 B | ||
|
Glaukos Corporation
GKOS
|
33.7 M | $ 111.73 | 2.6 % | $ 5.41 B | ||
|
Masimo Corporation
MASI
|
103 M | $ 137.35 | -0.72 % | $ 7.32 B | ||
|
Haemonetics Corporation
HAE
|
116 M | $ 80.24 | -3.89 % | $ 4.04 B | ||
|
InfuSystem Holdings
INFU
|
13.4 M | $ 9.22 | -0.27 % | $ 190 M | ||
|
Merit Medical Systems
MMSI
|
103 M | $ 86.49 | -0.24 % | $ 5.04 B | ||
|
Isoray
ISR
|
2.31 M | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
439 M | $ 559.7 | 3.2 % | $ 199 B | ||
|
OraSure Technologies
OSUR
|
10.9 M | $ 2.49 | - | $ 185 M | ||
|
Microbot Medical
MBOT
|
106 K | $ 2.23 | -7.65 % | $ 22.7 M | ||
|
Milestone Scientific
MLSS
|
37.4 K | $ 0.36 | -7.4 % | $ 28.7 M | ||
|
Nephros
NEPH
|
214 K | $ 4.98 | -0.8 % | $ 51.7 M | ||
|
NeuroMetrix
NURO
|
94 K | - | 5.05 % | $ 9.02 M | ||
|
ResMed
RMD
|
160 M | $ 251.67 | -0.27 % | $ 36.8 B | ||
|
Envista Holdings Corporation
NVST
|
123 M | $ 22.07 | 0.46 % | $ 3.8 B | ||
|
Pro-Dex
PDEX
|
1.24 M | $ 44.0 | 1.43 % | $ 145 M | ||
|
STAAR Surgical Company
STAA
|
6.89 M | $ 23.49 | -2.65 % | $ 1.15 B | ||
|
STERIS plc
STE
|
476 M | $ 253.98 | 0.82 % | $ 25 B | ||
|
Stereotaxis
STXS
|
595 K | $ 2.35 | -1.05 % | $ 190 M | ||
|
Pulse Biosciences
PLSE
|
542 K | $ 14.04 | -1.4 % | $ 674 M | ||
|
Predictive Oncology
POAI
|
162 K | - | - | $ 32.4 M | ||
|
Repligen Corporation
RGEN
|
68.6 M | $ 160.09 | 1.72 % | $ 8.92 M | ||
|
Utah Medical Products
UTMD
|
623 K | $ 57.54 | -0.96 % | $ 209 M | ||
|
DENTSPLY SIRONA
XRAY
|
349 M | $ 11.43 | -1.21 % | $ 2.32 B | ||
|
Retractable Technologies
RVP
|
7.57 M | $ 0.84 | 1.99 % | $ 25.1 M | ||
|
Teleflex Incorporated
TFX
|
275 M | $ 126.88 | 0.17 % | $ 5.94 B | ||
|
West Pharmaceutical Services
WST
|
155 M | $ 271.82 | 1.6 % | $ 19.8 B |